Come up with a name for your new list and we'll add to it:
Sangart raised a round of funding on October 05, 2010. Investors include
U.S. Department of Defense.
Sangart is a biopharmaceutical company focused on oxygen-therapeutic agents, providing products to patients in need. Sangart was founded in 1998 based on discoveries arising from over two decades of …